USP7-IN-13 (Compound 101) is a USP7 inhibitor with an IC50 value of 0.2-1 μM, which can be used for the study of multiple myeloma.
References:
[1]. Buhrlage, Sara, et al. Novel usp7 inhibitors for treating multiple myeloma. U.S. Patent. WO2019067503. 2019-04-04
















